MALE Mamm Organoids
Recruiting · NCT06786663 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →What this trial is about
It is believed that the use of organoids derived from male breast tumors can be of fundamental support for the definition of the molecular mechanisms underlying the onset of the tumor. Furthermore, the development of such preclinical models could be of significant support for the identification of specific personalized and ad hoc therapeutic treatments for male pathology.
Who can take part
Age range
18 Years and older
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Men aged \>18 years
- Patients with histologically confirmed breast cancer with or without synchronous metastases, who will undergo the relevant surgical intervention
- Adequate biological material to be able to carry out the analyses described above
- Signing of the relevant informed consent form
Exclusion criteria
- not present
Where it is running
1 location listed.
- IRCCS National Cancer Institute "Regina Elena" - Rome, Italy